FDA NDC Directory · JSON-LD · Markdown

Myrbetriq

NDC 0469-2602 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED, EXTENDED RELEASE

Generic namemirabegron
Labeler / ManufacturerAstellas Pharma US, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA202611
Dosage form / routeTABLET, FILM COATED, EXTENDED RELEASE · ORAL
Active ingredientsMIRABEGRON (50 mg/1)
Marketing started20120628
Package count3

External sources

Source: openFDA. Public-domain (CC0).